Clinical Trial Update: Safety Study of the Drug RG1068 in Patients With Obsessive Compulsive Disorder [Phase 2]

View source ↗

Summary

Phase 2 safety study of RG1068 in obsessive-compulsive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• RG1068

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Obsessive Compulsive Disorder (OCD) | Phase 2 | Status: COMPLETED